These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 31755778)

  • 1. Clinicopathologic and Prognostic Significance of Gallbladder and Cystic Duct Invasion in Distal Bile Duct Carcinoma.
    Jun SY; An S; Sung YN; Park Y; Lee JH; Hwang DW; Hong SM
    Arch Pathol Lab Med; 2020 Jun; 144(6):755-763. PubMed ID: 31755778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pancreatic and duodenal invasion in distal bile duct cancer: paradox in the tumor classification of the American Joint Committee on Cancer.
    Ebata T; Nagino M; Nishio H; Igami T; Yokoyama Y; Nimura Y
    World J Surg; 2007 Oct; 31(10):2008-15. PubMed ID: 17661132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic Significance of Intratumoral and Peritumoral Budding in Distal Extrahepatic Bile Duct Carcinoma.
    Jun SY; Hong SM; An S
    Pathobiology; 2024; 91(4):254-267. PubMed ID: 38113866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathologic study of resected cases of primary carcinoma of the cystic duct.
    Kubota K; Kakuta Y; Inayama Y; Yoneda M; Abe Y; Inamori M; Kirikoshi H; Saito S; Nakajima A; Sugimori K; Matuo K; Kazunaga T; Shimada H
    Hepatogastroenterology; 2008; 55(85):1174-8. PubMed ID: 18795652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of lymph node metastasis and surgical margin status for distal cholangiocarcinoma.
    Murakami Y; Uemura K; Hayashidani Y; Sudo T; Hashimoto Y; Ohge H; Sueda T
    J Surg Oncol; 2007 Mar; 95(3):207-12. PubMed ID: 17278119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathological characteristics of early to advanced gallbladder carcinoma and extrahepatic cholangiocarcinoma.
    Kijima H; Wu Y; Yosizawa T; Suzuki T; Tsugeno Y; Haga T; Seino H; Morohashi S; Hakamada K
    J Hepatobiliary Pancreat Sci; 2014 Jul; 21(7):453-8. PubMed ID: 24591403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraductal papillary neoplasm of the bile duct: Assessment of invasive carcinoma and long-term outcomes using MRI.
    Lee S; Kim MJ; Kim S; Choi D; Jang KT; Park YN
    J Hepatol; 2019 Apr; 70(4):692-699. PubMed ID: 30553839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carcinoma of the extrahepatic bile duct: mode of spread and its prognostic implications.
    Yamaguchi K; Chijiiwa K; Saiki S; Shimizu S; Takashima M; Tanaka M
    Hepatogastroenterology; 1997; 44(17):1256-61. PubMed ID: 9356836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of the Eighth American Joint Committee on Cancer Staging System for Distal Bile Duct Carcinoma.
    Jun SY; Sung YN; Lee JH; Park KM; Lee YJ; Hong SM
    Cancer Res Treat; 2019 Jan; 51(1):98-111. PubMed ID: 29510611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Invasion Depth Measured in Millimeters is a Predictor of Survival in Patients with Distal Bile Duct Cancer: Decision Tree Approach.
    Min KW; Kim DH; Son BK; Kim EK; Ahn SB; Kim SH; Jo YJ; Park YS; Seo J; Oh YH; Oh S; Kim HY; Kwon MJ; Min SK; Park HR; Choe JY; Jeon JY; Ha HI; Lee JW
    World J Surg; 2017 Jan; 41(1):232-240. PubMed ID: 27549598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macroscopic types of intrahepatic cholangiocarcinoma: clinicopathologic features and surgical outcomes.
    Hirohashi K; Uenishi T; Kubo S; Yamamoto T; Tanaka H; Shuto T; Kinoshita H
    Hepatogastroenterology; 2002; 49(44):326-9. PubMed ID: 11995443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multivariate statistical analysis of clinicopathologic factors influencing survival of patients with bile duct carcinoma.
    He P; Shi JS; Chen WK; Wang ZR; Ren H; Li H
    World J Gastroenterol; 2002 Oct; 8(5):943-6. PubMed ID: 12378647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carcinoma of the cystic duct remnant with direct colonic invasion.
    Noji T; Kondo S; Hirano S; Ambo Y; Tanaka E; Okushiba S; Katoh H
    Int J Gastrointest Cancer; 2003; 34(2-3):117-20. PubMed ID: 15361644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of tumor spread to the cystic duct on the prognosis of patients with gallbladder carcinoma.
    Nakata T; Kobayashi A; Miwa S; Soeda J; Miyagawa S
    World J Surg; 2007 Jan; 31(1):155-61; discussion 162-3. PubMed ID: 17180477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factors of surgical resection in middle and distal bile duct cancer: an analysis of 55 patients concerning the significance of ductal and radial margins.
    Sakamoto Y; Kosuge T; Shimada K; Sano T; Ojima H; Yamamoto J; Yamasaki S; Takayama T; Makuuchi M
    Surgery; 2005 Apr; 137(4):396-402. PubMed ID: 15800484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multivariate analysis by Cox Proportional Hazards Model on prognoses of patients with bile duct carcinoma after resection.
    He P; Shi J; Chen W; Wang Z
    Chin Med J (Engl); 2002 Oct; 115(10):1538-41. PubMed ID: 12490105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The expression of matrix metalloproteinases in intrahepatic cholangiocarcinoma, hilar (Klatskin tumor), middle and distal extrahepatic cholangiocarcinoma, gallbladder cancer, and ampullary carcinoma: role of matrix metalloproteinases in tumor progression and prognosis.
    Kirimlioğlu H; Türkmen I; Başsüllü N; Dirican A; Karadağ N; Kirimlioğlu V
    Turk J Gastroenterol; 2009 Mar; 20(1):41-7. PubMed ID: 19330734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathological review of 61 patients with early bile duct cancer.
    Cha JM; Kim MH; Lee SK; Seo DW; Lee SS; Lee JH; Lee SG; Jang SJ
    Clin Oncol (R Coll Radiol); 2006 Nov; 18(9):669-77. PubMed ID: 17100152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of Tumor Markers and Their Impact on Prognosis in Gallbladder, Bile Duct and Cholangiocellular Carcinomas - A Pilot Study.
    Liska V; Treska V; Skalicky T; Fichtl J; Bruha J; Vycital O; Topolcan O; Palek R; Rosendorf J; Polivka J; Holubec L
    Anticancer Res; 2017 Apr; 37(4):2003-2009. PubMed ID: 28373474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Biopathological characteristics of hilar cholangiocarcinoma and the clinical significance].
    Yu WL; Zhang YJ; Dong H; Yu H; Xian ZH; Wu MC; Cong WM
    Zhonghua Wai Ke Za Zhi; 2009 Aug; 47(15):1162-6. PubMed ID: 20021908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.